BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25657307)

  • 1. P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.
    Diaz JA; Wrobleski SK; Alvarado CM; Hawley AE; Doornbos NK; Lester PA; Lowe SE; Gabriel JE; Roelofs KJ; Henke PK; Schaub RG; Wakefield TW; Myers DD
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):829-37. PubMed ID: 25657307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation.
    Meier TR; Myers DD; Wrobleski SK; Zajkowski PJ; Hawley AE; Bedard PW; Ballard NE; Londy FJ; Kaila N; Vlasuk GP; Schaub RG; Wakefield TW
    Thromb Haemost; 2008 Feb; 99(2):343-51. PubMed ID: 18278184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new way to treat proximal deep venous thrombosis using E-selectin inhibition.
    Myers D; Lester P; Adili R; Hawley A; Durham L; Dunivant V; Reynolds G; Crego K; Zimmerman Z; Sood S; Sigler R; Fogler W; Magnani J; Holinstat M; Wakefield T
    J Vasc Surg Venous Lymphat Disord; 2020 Mar; 8(2):268-278. PubMed ID: 32067728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis.
    Ramacciotti E; Myers DD; Wrobleski SK; Deatrick KB; Londy FJ; Rectenwald JE; Henke PK; Schaub RG; Wakefield TW
    Thromb Res; 2010 Apr; 125(4):e138-42. PubMed ID: 19962723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation.
    Myers DD; Wrobleski SK; Longo C; Bedard PW; Kaila N; Shaw GD; Londy FJ; Rohrer SE; Fex BA; Zajkowski PJ; Meier TR; Hawley AE; Farris DM; Ballard NE; Henke PK; Schaub RG; Wakefield TW
    Thromb Haemost; 2007 Mar; 97(3):400-7. PubMed ID: 17334507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis.
    Downing LJ; Wakefield TW; Strieter RM; Prince MR; Londy FJ; Fowlkes JB; Hulin MS; Kadell AM; Wilke CA; Brown SL; Wrobleski SK; Burdick MD; Anderson DC; Greenfield LJ
    J Vasc Surg; 1997 May; 25(5):816-27; discussion 828. PubMed ID: 9152309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-selectin inhibitor is superior to low-molecular-weight heparin for the treatment of experimental venous thrombosis.
    Myers DD; Ning J; Lester P; Adili R; Hawley A; Durham L; Dunivant V; Reynolds G; Crego K; Sood S; Sigler R; Fogler WE; Magnani JL; Holinstat M; Wakefield T
    J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):211-220. PubMed ID: 33872819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis.
    Myers DD; Henke PK; Bedard PW; Wrobleski SK; Kaila N; Shaw G; Meier TR; Hawley AE; Schaub RG; Wakefield TW
    J Vasc Surg; 2006 Sep; 44(3):625-32. PubMed ID: 16950445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced Obesity.
    Michels A; Dwyer CN; Mewburn J; Nesbitt K; Kawecki C; Lenting P; Swystun LL; Lillicrap D
    Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2860-2874. PubMed ID: 32967458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model.
    Diaz JA; Hawley AE; Alvarado CM; Berguer AM; Baker NK; Wrobleski SK; Wakefield TW; Lucchesi BR; Myers DD
    Thromb Haemost; 2010 Aug; 104(2):366-75. PubMed ID: 20589322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels.
    Nimjee SM; Dornbos D; Pitoc GA; Wheeler DG; Layzer JM; Venetos N; Huttinger A; Talentino SE; Musgrave NJ; Moody H; Rempel RE; Jones C; Carlisle K; Wilson J; Bratton C; Joseph ME; Khan S; Hoffman MR; Sommerville L; Becker RC; Zweier JL; Sullenger BA
    Mol Ther; 2019 Jul; 27(7):1228-1241. PubMed ID: 30987839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased venous thrombosis with an oral inhibitor of P selectin.
    Myers DD; Rectenwald JE; Bedard PW; Kaila N; Shaw GD; Schaub RG; Farris DM; Hawley AE; Wrobleski SK; Henke PK; Wakefield TW
    J Vasc Surg; 2005 Aug; 42(2):329-36. PubMed ID: 16102635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline.
    Sood V; Luke C; Miller E; Mitsuya M; Upchurch GR; Wakefield TW; Myers DD; Henke PK
    Ann Vasc Surg; 2010 Feb; 24(2):233-41. PubMed ID: 20142002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy.
    Wakefield TW; Strieter RM; Schaub R; Myers DD; Prince MR; Wrobleski SK; Londy FJ; Kadell AM; Brown SL; Henke PK; Greenfield LJ
    J Vasc Surg; 2000 Feb; 31(2):309-24. PubMed ID: 10664500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model.
    Myers DD; Henke PK; Wrobleski SK; Hawley AE; Farris DM; Chapman AM; Knipp BS; Thanaporn P; Schaub RG; Greenfield LJ; Wakefield TW
    J Vasc Surg; 2002 Nov; 36(5):928-38. PubMed ID: 12422103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model.
    Thanaporn P; Myers DD; Wrobleski SK; Hawley AE; Farris DM; Wakefield TW; Henke PK
    Surgery; 2003 Aug; 134(2):365-71. PubMed ID: 12947342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergic effect of
    Li D; Zhang X; Zhang H; Li X
    Vascular; 2020 Jun; 28(3):309-313. PubMed ID: 31902309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic effect of grape seed proanthocyanidins extract in a rat model of deep vein thrombosis.
    Zhang Y; Shi H; Wang W; Ke Z; Xu P; Zhong Z; Li X; Wang S
    J Vasc Surg; 2011 Mar; 53(3):743-53. PubMed ID: 21095090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1D-¹H-nuclear magnetic resonance metabolomics reveals age-related changes in metabolites associated with experimental venous thrombosis.
    Obi AT; Stringer KA; Diaz JA; Finkel MA; Farris DM; Yeomans L; Wakefield T; Myers DD
    J Vasc Surg Venous Lymphat Disord; 2016 Apr; 4(2):221-30. PubMed ID: 26993871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGL-Ig.
    Myers D; Wrobleski S; Londy F; Fex B; Hawley A; Schaub R; Greenfield L; Wakefield T
    Thromb Haemost; 2002 Mar; 87(3):374-82. PubMed ID: 11916067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.